Louis Champion
Direttore/Membro del Consiglio presso Stallergenes Ibérica SA
Provenienza dei contatti di primo grado di Louis Champion
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
17
| Subsidiary | Pharmaceuticals: Major | 17 |
| Public Company | Biotechnology | 5 | |
Stallergenes Italia Srl
 Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation.
2
| Subsidiary | Medical Distributors | 2 |
Stallergenes Ibérica SA
1
| Subsidiary | Wholesale Distributors | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Louis Champion tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Here Holding Corp.
 Here Holding Corp. Data Processing ServicesTechnology Services Here Holding Corp. provides digital maps and map content processing services. It provides technical services, including strategic program management, technical customer support, system assessment testing, and customer engineering services. The company was founded in 1985 and is headquartered in Chicago, IL. | Data Processing Services | Director/Board Member | |
| WENDEL | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| TIGENIX NV | Medical Specialties | Director of Finance/CFO | |
| Stanford University | College/University | Masters Business Admin | |
Esaote SpA
 Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| MEDIGENE AG | Biotechnology | Chairman | |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| BIOMÉRIEUX | Medical Specialties | Director/Board Member Sales & Marketing | |
Chiron Behring & Co.
 Chiron Behring & Co. Medical DistributorsDistribution Services Part of Novartis AG, Chiron Behring & Co. is a German company that supplies and develops new vaccine products for adults and children. The company is based in Marburg, Germany. Chiron Behring was acquired by Chiron Corp. from Hoechst AG on April 01, 1998 for $111.90 million. | Medical Distributors | Chief Executive Officer | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Patrimonia SA
 Patrimonia SA Real Estate DevelopmentFinance Part of Lamy SA, Patrimonia SA specializes in real-estate management services. The company is based in Paris, France. Patrimonia was acquired by Gestrim SA on April 19, 2004. | Real Estate Development | Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| University of Regensburg | College/University | Doctorate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree Masters Business Admin | |
Deutsch Group SAS
 Deutsch Group SAS Electronic ComponentsElectronic Technology Deutsch Group SAS operates as a holding company with interests in designing and manufacturing connectors and relays. The company was founded in 1938 and is headquartered in Pontoise, France. | Electronic Components | Director/Board Member | |
Wendel SE (Private Equity)
 Wendel SE (Private Equity) Investment ManagersFinance Wendel SE (Private Equity) is the Private Equity arm of the Wendel Group (MF) founded in 1977. Wendel SE is headquartered in Paris with additional offices around the world. | Investment Managers | Director/Board Member | |
CSP Technologies, Inc.
 CSP Technologies, Inc. Chemicals: SpecialtyProcess Industries CSP Technologies, Inc. provides polymeric and packaging solutions. It offers closure integrity testing, performance testing, microbial studies, and design and installation of specialized packaging. The firm's products include vials, films, blisters, specialty activated components, specialized packaging solutions and drug delivery solutions / medical devices. The company was founded in 1928 and is headquartered in Auburn, AL. | Chemicals: Specialty | Director/Board Member | |
| Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree | |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Director of Finance/CFO Private Equity Investor Private Equity Investor | |
| Infinity Discovery, Inc. | Director/Board Member | ||
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
European Biopharmaceutical Enterprises
 European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | President | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Institut Mérieux SA provides solutions for multifactorial management of diseases. The firm provides solutions for diseases, including tuberculosis, liver cancer and hepatitis. It specializes in the field human and veterinary of vaccines. It operates under the activities of diagnostics, immunotherapy and nutrition. The company was founded by Marcel Mérieux in 1897 and is headquartered Lyon, France. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Zambon SpA
 Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Helmholtz-Zentrum für Infektionsforschung GmbH
 Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Biotechnology | Director/Board Member | |
Merck Serono SAS
 Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Operating Officer | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Stallergenes Belgium SA
 Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Pharmaceuticals: Major | Chairman Chairman | |
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
 MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. develops and researches vaccines. The joint venture company is based in Gurgaon, India. The company was founded in 2009. Raman Rao has been the CEO of the Indian company since 2020. | Biotechnology | Chairman | |
| Stallergenes, Inc. | Director/Board Member Director/Board Member | ||
| Steadfast Advisory Partners LLP | Corporate Officer/Principal | ||
Association Hospitaliere de Bruxelles & de Schaerbeek
 Association Hospitaliere de Bruxelles & de Schaerbeek Hospital/Nursing ManagementHealth Services Ziekenhuisvereniging van Brussel en van Schaarbeek University provides public general hospital services. The non-profit company is based in Brussels, Belgium. | Hospital/Nursing Management | Corporate Officer/Principal | |
IXALTIS SAS
 IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Founder | |
| Hôpital Universitaire Des Enfants Reine Fabiola | Corporate Officer/Principal | ||
| Wendel North America | Investment Managers | Chief Executive Officer | |
Kuste Biopharma SAS
 Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chairman | |
| STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Francia | 16 |
| Stati Uniti | 12 |
| Belgio | 8 |
| Italia | 5 |
| Germania | 5 |
Settori
| Health Technology | 25 |
| Finance | 8 |
| Consumer Services | 7 |
| Health Services | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 130 |
| Corporate Officer/Principal | 44 |
| Chairman | 33 |
| Independent Dir/Board Member | 27 |
| Chief Executive Officer | 23 |
Contatti più connessi
| Insiders | |
|---|---|
| Jean-Luc Bélingard | 40 |
| Jean-Paul Prieels | 32 |
| Patrick J. Langlois | 23 |
| Jacques Theurillat | 22 |
| Dirk-Jan van Ommeren | 15 |
| Patrick Lee | 15 |
| Albert Saporta | 15 |
| David Darmon | 14 |
| Paola Ricci | 11 |
| Gerd Zettlmeissl | 11 |
| Maria Gabriella Camboni | 11 |
| Roberto Gradnik | 11 |
| Robert Zeldin | 9 |
| Thibaut du Fayet | 8 |
| Frank Hazevoets | 7 |
- Borsa valori
- Insiders
- Louis Champion
- Connessioni Società
